CVRx® Secures $113 Million in New Financing

by Ysios Capital

CVRx, Inc., a private medical device company, has secured equity financing totaling $93 million and a new $20 million debt facility. CVRx plans to use the proceeds for the primary purposes of completi...

Read more

Parkinson’s disease: Prexton Therapeutics, participated by Ysios Capital, completes phase 1 clinical trial

by Ysios Capital

Study shows mGluR4 positive allosteric modulator is safe and well tolerated at doses well above those that produce robust effects in Parkinson’s disease animal models

Read more

Inveready lidera una ronda de € 3,5 millones en Leukos Biotech, la spin-out del prestigioso Instituto de Investigación contra la leucemia Josep Carreras

by Inveready

La ronda avanzará un primer candidato a ensayos clínicos para la leucemia mieloide aguda (LMA) en pacientes definidos como no aptos o “unfit”, es decir, mayores de 60 años cuyo estado de salud ...

Read more

STAT-Diagnostica attracts Siemens Venture Capital as a new investor

by Ysios Capital

“STAT-Diagnostica has an exciting technology that could significantly advance the diagnosis and triage of infectious diseases. We are impressed with the team and look forward to working with them in...

Read more

CorWave Raises $17.1 Million in Series B Financing

by Ysios Capital

CorWave, a medical technology company that develops innovative mechanical circulatory support devices, has announced that it has completed a $17.1 million (€15.5M) Series B financing. Existing share...

Read more

OxThera raises EUR 32 million to complete development of Oxabact® for treatment of Primary hyperoxaluria

by Ysios Capital

Primary hyperoxaluria (PH) is a rare autosomal recessive disorder leading to markedly elevated levels of endogenous oxalate causing kidney deterioration and a gradual calcification of soft tissues. If...

Read more

TiGenix, participated by Ysios Capital, announces launch of proposed initial public offering in the United States

by TIGENIX SAU

TiGenix NV (Euronext Brussels: TIG), an advanced biopharmaceutical company focused on developing and commercialising novel therapeutics from its proprietary platforms of allogeneic expanded stem cells...

Read more

InKemia invierte 100.000 € en la empresa del sector CleanTech - Bioo – que dispone de la tecnología para generar electricidad a partir de las plantas

by InKemia IUCT group

El reto que se plantea la empresa es proveer de electricidad a las ciudades, empresas y viviendas con la energía generada por sus jardines.Las innovaciones presentadas por Bioo se basan en la integra...

Read more

BioClin Therapeutics, Inc., Raises $30 Million in Series B Financing Led by Sofinnova Ventures and Ysios Capital

by Ysios Capital

The financing was led by new investors Sofinnova Ventures and Ysios Capital, and included existing investors HealthCap, Life Sciences Partners (LSP), and Tekla Capital Management. Since its founding, ...

Read more

InKemia refuerza su participación en Recerca Clínica hasta el 51% del capital

by InKemia IUCT group

InKemia informa que el grupo ha realizado la compra de las participaciones del segundo mayor accionista de Recerca Clínica, S.L. por valor de 75.000 euros. Así mismo suscribe una ampliación de capi...

Read more

Oryzon Raises €18 Million through a Private Placement with US and European Investors

by Oryzon Genomics

The offering included institutional investors specialized in healthcare and life sciences from the US, Spain and rest of Europe. The majority of the funds were raised from international investors, rei...

Read more

V Foro de Inversión Biotech Capital Cell - Madrid

by Professional Newco

Desde 2015, Capital Cell ha levantado 13 rondas de inversión por un total de más de €4M para empresas que estan llevando al mercado nuevos tratamientos contra el cáncer infantil, el Alzheimer, la...

Read more
Subscribe to Directory
Write an Article

Recent News

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...

Highlight

Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

A chip against chronic bacterial infecti...

by IBEC - Institut de Bioenginyeria de Catalunya

IBEC researchers develop a device that allows to grow biofilms and ana...

Photos Stream